Willamette Valley Vineyards Inc. and ShiftPixy Inc. in race to be NASDAQ top performer of the day
The National Association of Securities Dealers Automated Quotations (NASDAQ) Composite Index opened at 14,204.51 on 29th April 2021. Till 1 PM the highest it touched was 14,211.57 and lowest 13,952.80
Top 5 Performers Till 1 PM:
Willamette Valley Vineyards Inc. (Change 55% Priced at $15.7)
Willamette Valley Vineyards, Inc. engages in the production and sale of premium, super premium and ultra premium varietal wines. It operates through the Direct Sales and Distributor Sales segments. The Direct Sales segment includes retail sales made without use of an intermediary. The Distributor Sales segment involves the sales through third party where prices are given at a wholesale rate The company was founded by James W. Bernau in 1983 and is headquartered in Turner, OR.
ShiftPixy Inc. (Change 19.12% Priced at $2.9)
ShiftPixy, Inc. provides human capital services, revolutionizing employment in the Gig Economy by delivering a next-gen platform for workforce management that helps businesses with shift-based employees navigate regulatory mandates, minimize administrative burdens, and better connect with a ready-for-hire workforce. The firm’s complete human capital management ecosystem is designed to manage regulatory requirements and compliance in such required areas as paid time off (PTO) laws, insurance and workers compensation, minimum wage increases, and Affordable Care Act (ACA) compliance. ShiftPixy was founded by Scott W. Absher and J. Stephen Holmes on June 3, 2015 and is headquartered in Miami, FL.
Galera Therapeutics Inc. (Change 22.47% Priced at $8)
Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The firm involves in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. Its product candidate GC4419 reduces severe oral mucositis in patients with head and neck cancer undergoing radiation therapy and also receiving cisplatin, a chemotherapy drug. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Ocular Therapeutix Inc. (Change 23.32% Priced at $19.2)
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
JAKKS Pacific Inc. (Change 21.81% Priced at $8.9)
JAKKS Pacific, Inc. engages in the design, development, and sale of toys, consumables, electronics, kid’s indoor and outdoor furniture, and other consumer products. It operates through the following business segments: United States and Canada, International and Halloween. The United States and Canada segment includes action figures, vehicles, play sets, plush products, dolls, electronic products, construction toys, infant and pre-school toys, role play and everyday costume play, foot to floor ride-on vehicles, wagons, novelty toys, seasonal and outdoor products, kids’ indoor and outdoor furniture, and pet treats, and related products, primarily within the United States and Canada. The International segment is responsible for the marketing and sale of toy products in markets outside of the United States and Canada, primarily in the European, Asia Pacific, and Latin and South American regions. The Halloween segment is the marketing and sale of Halloween costumes and accessories and everyday costume play products, primarily in the United States and Canada. The company was founded by Stephen G. Berman and Jack Friedman in January 1995 and is headquartered in Santa Monica, CA.